The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...
Funny how a development so significant could be no more than a blip on the screen on occasion. Perhaps I missed the entire Vernakalant development story because I read about the compound RSD1235 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results